Balchem Corporation Total Assets

Latest as of March 2026: $1.69 Billion USD

Balchem Corporation total assets. Based on the latest financial reports, Balchem Corporation (BCPC) holds total assets worth $1.69 Billion USD as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BCPC company net worth for the company's overall valuation and market capitalisation.

Total Assets of Balchem Corporation (1985–2025)

Total assets of Balchem Corporation from 1985 to 2025. This chart illustrates how Balchem Corporation's total assets have evolved over time, based on quarterly financial data. See Balchem Corporation stock price for real-time trading data and today's change.

Balchem Corporation - Asset Composition Analysis

Balchem Corporation Total Assets Breakdown (December 2025)

Balchem Corporation total assets breakdown as of December 2025. Balchem Corporation's total assets of $1.69 Billion consist of 21.4% current assets and 78.6% non-current assets.

Asset Category Amount (USD) % of Total Assets
Cash & Equivalents $0.00 4.4%
Accounts Receivable $143.60 Million 8.4%
Inventory $131.45 Million 7.7%
Property, Plant & Equipment $0.00 0.0%
Intangible Assets $163.29 Million 9.6%
Goodwill $816.38 Million 47.8%

Asset Composition Trend (1985–2025)

This chart illustrates how Balchem Corporation's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of Balchem Corporation to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Balchem Corporation's current assets represent 21.4% of total assets in 2025, a decrease from 38.9% in 1985.
  • Cash Position: Cash and equivalents constituted 4.4% of total assets in 2025, up from 0.0% in 1985.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 56.0% of total assets, an increase from 0.0% in 1985.
  • Asset Diversification: The largest asset category is goodwill at 47.8% of total assets.

Balchem Corporation Competitors by Total Assets

Key competitors of Balchem Corporation based on total assets are shown below.

Company Country Total Assets
Hengyi Petrochemical Co Ltd
SHE:000703
China CN¥122.44 Billion
Akzo Nobel NV
AS:AKZA
Netherlands €13.95 Billion
LB Group Co Ltd
SHE:002601
China CN¥63.89 Billion
Suzhou TA&A Ultra Clean Technology Co Ltd
SHE:300390
China CN¥27.92 Billion
Cngr Advanced Material Co Ltd
SHE:300919
China CN¥83.43 Billion
Qingdao Gon Technology Co Ltd
SHE:002768
China CN¥22.59 Billion
Shenzhen Chengxin Lithium Group Co Ltd
SHE:002240
China CN¥25.50 Billion
Borregaard ASA
OL:BRG
Norway Nkr9.51 Billion

Balchem Corporation - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 2.55 2.44 2.85
Quick Ratio 1.59 1.40 2.07
Cash Ratio 0.00 0.00 0.00
Working Capital $236.40 Million $200.68 Million $186.50 Million

Balchem Corporation - Advanced Valuation Insights

This section examines the relationship between Balchem Corporation's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 4.02
Latest Market Cap to Assets Ratio 3.03
Asset Growth Rate (YoY) 8.4%
Total Assets $1.71 Billion
Market Capitalization $5.17 Billion USD

Valuation Analysis

Premium Asset Valuation: The market values Balchem Corporation's assets at a significant premium (3.03x), suggesting investors see substantial growth potential or unique competitive advantages.

Positive Asset Growth: Balchem Corporation's assets grew by 8.4% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Balchem Corporation (1985–2025)

The table below shows the annual total assets of Balchem Corporation from 1985 to 2025.

Year Total Assets Change
2025-12-31 $1.71 Billion +8.39%
2024-12-31 $1.58 Billion -1.37%
2023-12-31 $1.60 Billion -1.68%
2022-12-31 $1.62 Billion +35.45%
2021-12-31 $1.20 Billion +2.87%
2020-12-31 $1.17 Billion +0.88%
2019-12-31 $1.16 Billion +17.76%
2018-12-31 $981.36 Million +1.84%
2017-12-31 $963.64 Million +1.58%
2016-12-31 $948.63 Million +7.65%
2015-12-31 $881.22 Million +2.32%
2014-12-31 $861.27 Million +128.53%
2013-12-31 $376.87 Million +20.58%
2012-12-31 $312.55 Million +15.03%
2011-12-31 $271.72 Million +18.85%
2010-12-31 $228.62 Million +21.73%
2009-12-31 $187.81 Million +21.58%
2008-12-31 $154.47 Million +0.03%
2007-12-31 $154.42 Million +67.25%
2006-12-31 $92.33 Million +22.88%
2005-12-31 $75.14 Million +24.40%
2004-12-31 $60.41 Million +6.15%
2003-12-31 $56.91 Million +6.77%
2002-12-31 $53.30 Million +19.83%
2001-12-31 $44.48 Million +91.53%
2000-12-31 $23.22 Million +5.55%
1999-12-31 $22.00 Million -2.65%
1998-12-31 $22.60 Million +28.41%
1997-12-31 $17.60 Million +16.56%
1996-12-31 $15.10 Million +5.59%
1995-12-31 $14.30 Million +16.26%
1994-12-31 $12.30 Million +33.70%
1993-12-31 $9.20 Million +21.05%
1992-12-31 $7.60 Million 0.00%
1991-12-31 $7.60 Million +26.67%
1990-12-31 $6.00 Million +9.09%
1989-12-31 $5.50 Million -5.17%
1988-12-31 $5.80 Million +20.83%
1987-12-31 $4.80 Million +26.32%
1986-12-31 $3.80 Million +5.56%
1985-12-31 $3.60 Million --

About Balchem Corporation

NASDAQ:BCPC USA Specialty Chemicals
Market Cap
$5.64 Billion
Market Cap Rank
#3383 Global
#1212 in USA
Share Price
$175.51
Change (1 day)
+0.52%
52-Week Range
$147.36 - $183.26
All Time High
$183.41
About

Balchem Corporation develops, manufactures, and distributes specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products. The Human Nutrition & Health segment… Read more